Reconsideration of antenatal corticosteroid for pregnancy and the risk of serious infection-Reference-Cited by-同舟云学术

Reconsideration of antenatal corticosteroid for pregnancy and the risk of serious infection

Published:2024-08 Issue:8 Volume:27 Page:
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J of Rheum Dis

Author:

Gao Xianfei¹²,Huang Chunlin³⁴,Zeng Haisheng⁵,Chen Ruixin¹,Liu Dexin⁶,Zeng Huasong¹²^ORCID

Affiliation:

1. Department of Pediatric Allergy, Immunology and Rheumatology, Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou China

2. Guangdong Province Key Laboratory of Allergy & Clinical Immunology Guangzhou Medical University Guangzhou China

3. Department of Immunology and Rheumatology Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region Nanning Guangxi China

4. Research Center for Pediatric Diseases Nanning Guangxi China

5. Department of Rheumatology and Immunology, Dongguan Children's Hospital, Dongguan Maternal and Child Health Hospital Guangdong Medical University Dongguan Guangdong Province China

6. Department of Pediatric, Allergy Immune and Rheumatology Liuzhou Hospital, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, National Children's Medical Center for Central and South China Region Guangzhou China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.15281

Reference7 articles.

1. Editorial: Antenatal corticosteroids for pregnancy and risk of serious infection—Revisiting the role of antenatal corticosteroids

2. The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries

3. Association between antenatal corticosteroid use and perinatal mortality among preterm births in hospitals in Tanzania

4. The Antenatal Corticosteroids Trial (ACT): a secondary analysis to explore site differences in a multi-country trial

5. Antenatal Corticosteroids for Pregnant Women at High Risk of Preterm Delivery with COVID-19 Infection: A Decision Analysis